News about Drug Discovery & Development

Orchid Pharma Gets DCGI Approval for Enmetazobactam

Orchid Pharma has secured Drugs Controller General of India (DCGI) approval for the manufacturing and marketing of its invented New Chemical Entity Active Pharmaceutical Ingredient (API), Enmetazobactam.

Drug Discovery & Development | 10/06/2024 | By Aishwarya |  739

Saghmos Gets US Patent for Phase 3-Ready Cardiorenal Metabolic Modulator

Saghmos Therapeutics, Inc. has announced that the US Patent and Trademark Office (USPTO) has granted US Patent No. 11,986,473 titled, 'Prevention and/or Treatment of Contrast-Induced Acute Kidney Injury' for its Phase 3-ready product, ST-62516.

Drug Discovery & Development | 06/06/2024 | By Aishwarya |  543

Lupin Gets Tentative Approval from US FDA for Letermovir Tablets

Lupin has secured a tentative approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application for Letermovir Tablets, 240 mg and 480 mg, to market a generic equivalent of Prevymis Tablets, 240 mg and 480 mg, of Merck Sharp & Dohme LLC.

Drug Discovery & Development | 05/06/2024 | By Aishwarya |  1029

Syngene Rolls Out New Platform for Enhanced Protein Production

Syngene International Ltd. has introduced its new protein production platform.

Drug Discovery & Development | 05/06/2024 | By Aishwarya |  704

Bionova Scientific to Expand New Plasmid DNA GMP Facility

Bionova Scientific has decided to expand into plasmid DNA (pDNA) production.

Drug Discovery & Development | 04/06/2024 | By Aishwarya |  608

Telix Completes TLX250-CDx BLA Submission for Kidney Cancer Imaging

Telix Pharmaceuticals has completed the submission of a Biologics License Application (BLA) to the United States (US) Food and Drug Administration (FDA) for its investigational radiodiagnostic PET agent.

Drug Discovery & Development | 03/06/2024 | By Aishwarya |  394

GRIT and Quangang to Boost Localization of Interleukin-2

Shanghai Grit Biotechnology Co., Ltd. (GRIT) has forged a formal strategic partnership with Shandong Quangang Pharmaceutical Co., Ltd. (Quangang) to leverage both parties' R&D capabilities in innovative T-cell therapy.

Drug Discovery & Development | 01/06/2024 | By Aishwarya |  457

Navigate BioPharma Services Unveils New Assay for Precise Measurement of Radioligand Therapies

Navigate BioPharma Services, Inc. has introduced a new assay for quantifying pharmacodynamic markers of radioligand therapies in tumors.

Drug Discovery & Development | 01/06/2024 | By Aishwarya |  384

ModeX Signs Master Services Deal with ProBioGen to Accelerate COVID-19 Antibody Development

ProBioGen has partnered with ModeX Therapeutics an OPKO Health Company, dedicated to combating cancer and infectious diseases with cutting-edge multi-specific biologics.

Drug Discovery & Development | 31/05/2024 | By Aishwarya |  584

Lexicon Selects Medidata to Advance First Non-Opioid Drug for Neuropathic Pain

Medidata has been chosen by Lexicon Pharmaceuticals, Inc. to help advance PROGRESS, a Phase 2b study of LX9211 in diabetic peripheral neuropathic pain (DPNP), with the potential for LX9211 to become the first new, non-opioid drug approved for neuropathic pain in over two decades.

Drug Discovery & Development | 30/05/2024 | By Aishwarya |  414